Liraglutide News
Most Popular Liraglutide Story
FDA approves Novo's blockbuster diabetes drug
After an exhaustive 21-month review, the FDA has extended its approval for the blockbuster new type 2 diabetes drug Victoza (liraglutide). And the news quickly spurred shares of Novo Nordisk higher. Read more...
Latest Headlines
- January 26, 2010
- December 31, 2009
- October 23, 2009
- September 23, 2009
- August 6, 2009
- June 10, 2009
- June 8, 2009
- April 24, 2009
- April 3, 2009
- October 17, 2008
- July 29, 2008
- October 17, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
